Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" to Form 990, Part IV, line 23.
SchJMediumBullet Attach to Form 990.
SchJMediumBullet Information about Schedule J (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2014
Open to Public Inspection
Name of the organization
Scott & White Hospital-College Station
 
Employer identification number

27-4434451
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .........
1b
Yes
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..
2
Yes
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? ................
4a
Yes
 
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
 
No
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ...........................
5a
 
No
b
Any related organization?
5b
 
No
If "Yes," to line 5a or 5b, describe in Part III.
6
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization?
6a
 
No
b
Any related organization? .........................
6b
 
No
If "Yes," to line 6a or 6b, describe in Part III.
7
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
Yes
 
8
Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................
8
 
No
9
If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2014
Page 2

Schedule J (Form 990) 2014
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits
(E) Total of columns
(B)(i)-(D)
(F) Compensation in column(B) reported as deferred in prior Form 990
(i) Base compensation (ii) Bonus & incentive compensation (iii) Other reportable compensation
1Jason D JenningsDirector, President and CEO (i)
(ii)
204,861
.................
78,096
24,280
.................
9,256
2,856
.................
1,089
9,412
.................
3,588
9,605
.................
3,662
251,014
.................
95,691
0
.................
0
2Thomas P O'Shea MDDirector (i)
(ii)
0
.................
525,166
0
.................
55
0
.................
37,238
0
.................
33,800
0
.................
17,271
0
.................
613,530
0
.................
0
3Daniel G Ransom MDDirector (i)
(ii)
0
.................
269,246
0
.................
7
0
.................
4,601
0
.................
33,800
0
.................
12,469
0
.................
320,123
0
.................
0
4William L Rayburn MDDirector, Chief Medical Officer (i)
(ii)
0
.................
526,367
0
.................
63,244
0
.................
12,713
0
.................
32,659
0
.................
17,540
0
.................
652,523
0
.................
0
5Patricia M CurrieDirector, Secretary/Treasurer (i)
(ii)
0
.................
559,048
0
.................
391,893
0
.................
25,174
0
.................
15,763
0
.................
16,709
0
.................
1,008,587
0
.................
0
6Glen R Couchman MDDirector (i)
(ii)
0
.................
558,912
0
.................
391,859
0
.................
26,655
0
.................
15,763
0
.................
16,702
0
.................
1,009,891
0
.................
0
7Clayton R KolodziejczykChief Financial Officer (i)
(ii)
122,194
.................
46,582
10,980
.................
4,186
126
.................
48
6,874
.................
2,620
8,217
.................
3,132
148,391
.................
56,568
0
.................
0
8Brenda P DavisChief Operations Officer and CNO (i)
(ii)
165,739
.................
0
14,734
.................
0
216
.................
0
9,446
.................
0
11,254
.................
0
201,389
.................
0
0
.................
0
9Rachel A CrowderPharmacy Director (i)
(ii)
131,973
.................
0
9,050
.................
0
531
.................
0
6,157
.................
0
8,541
.................
0
156,252
.................
0
0
.................
0
10Drew S RobertsPharmacist (i)
(ii)
151,542
.................
0
3,664
.................
0
421
.................
0
3,542
.................
0
2,868
.................
0
162,037
.................
0
0
.................
0
11Rodney Light MDAssociate CMO (i)
(ii)
161,056
.................
69,024
3,505
.................
1,502
11,620
.................
4,980
8,841
.................
3,789
8,672
.................
3,716
193,694
.................
83,011
0
.................
0
12Dick L DixonFormer Officer (i)
(ii)
0
.................
20,341
0
.................
242,970
0
.................
376,258
0
.................
13,000
0
.................
689
0
.................
653,258
0
.................
0
13James CarrollFormer Officer (i)
(ii)
0
.................
35,571
0
.................
441,659
0
.................
655,755
0
.................
12,454
0
.................
1,158
0
.................
1,146,597
0
.................
0
Schedule J (Form 990) 2014
Page 3

Schedule J (Form 990) 2014
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II.
Also complete this part for any additional information.
Return Reference Explanation
Part I, Line 1a Tax indemnification and gross up payments - The organization provides tax indemnification where an authorized member of management determines there is justification to reimburse an individual for the tax impact on certain taxable, non-cash benefits provided to them. All tax indemnification payments provided are treated as taxable compensation. Nine of the persons listed in the Form 990, Part VII, Section A, received this benefit during the tax year.
Part I, Line 3 Process for determining compensation: The organization, a controlled affiliate of BSW Holdings, recognizes that those chosen to lead the organization are vital to its ongoing success and growth. Thus, it must attract, retain and engage the highest quality officers and key employees to lead the organization and help the organization maintain its national reputation for achieving high targets for medical quality, patient safety, and patient satisfaction. A significant portion of the organization's officers and key employees' total compensation is based on significant performance achievements. This strategy, known as the Annual Incentive Plan, places a greater emphasis on the importance of the organization achieving targeted improvements in the areas of people, quality, patient satisfaction and financial stewardship, annually. Total executive compensation is part of an integrated talent management strategy developed by the BSW Holdings' Board of Trustees and its Compensation and Governance Committee (C&G Committee) to attract, motivate, and retain the best leadership resources for the organization. Executive compensation is determined pursuant to guidelines outlined in the intermediate sanction rules under IRC Section 4958 including taking steps to meet the rebuttable presumption standard of reasonableness under Treasury Regulation 53.4958-6, as summarized below. When making compensation decisions, the organization compares itself to similar-sized, and structured businesses including other integrated health care service systems and other similar-sized organizations, both locally and nationally. The BSW Holdings' Board of Trustees and C&G Committee, on behalf of the organization, work directly with an independent compensation expert(s) to identify reasonable and competitive market rates as well as provide an annual review of the total compensation of the organization's top management officials and key employees. The C&G Committee is made up of members of the BSW Holdings' Board of Trustees, who are independent, community volunteers Guided by the information provided by the independent compensation expert(s), the C&G Committee approves and recommends to the BSW Holdings' Board of Trustees salary increases, earned incentives, and benefit offerings for the organization's President, other officers and/or key employees to be comparable to similar organizations for similar services and/or positions. Furthermore, the C&G Committee is charged with the responsibility of reviewing annually the major elements of the executive compensation program to assure designs remain consistent with the business needs, market practices, and compensation philosophy. As part of the decision making process, the C&G Committee will often meet in executive session to discuss and review recommendations made by the independent compensation expert(s). During the executive session no officer or key employee whose compensation is being reviewed is present during these discussions. All decisions are contemporaneously documented in the C&G Committee minutes which are timely reviewed and approved by the C&G Committee.
Part I, Line 4a Dick Dixon received a severance payment in the amount of $364,455 and James Carroll received a severance payment in the amount of $635,040.
Part I, Line 7 The organization has adopted and implemented BSW Holdings', the organization's ultimate parent, Annual Incentive Program to provide a market competitive total cash compensation incentive program that is designed to attract and retain key leaders and establish greater individual accountability and alignment to business performance. Payout targets are based upon a percentage of base pay and are developed by independent third party expert(s) using comparable market competitive data within the bounds of reasonableness and that are reviewed and approved by BSW Holdings' governing body. Payout levels are based upon a combination of system, entity, and individual performance using various metrics related to quality, patient satisfaction, employee retention, and financial stewardship. BSW Holdings' governing body may approve modifications to annual incentive awards provided under the program consistent with market comparability data.
Schedule J (Form 990) 2014

Additional Data


Software ID:  
Software Version: